Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient Reported Experiences and Comfort Associated with Intravitreal Injection Technique: A Cross-Sectional Survey Approach.

Journal of vitreoretinal diseases·2025

Same author

Supply Chain Volatility of Repackaged Intravitreal Bevacizumab: A Survey of the American Society of Retina Specialists.

Journal of vitreoretinal diseases·2025

Same author

Outcomes of Eyes Undergoing Silicone Oil Removal Following Complex Rhegmatogenous Retinal Detachment Repair.

Clinical & experimental ophthalmology·2025

Same author

Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.

Journal of vitreoretinal diseases·2024

Same author

Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices.

JAMA ophthalmology·2024

Same author

MANAGEMENT OF LARGE FULL-THICKNESS MACULAR HOLES: Long-Term Outcomes of Internal Limiting Membrane Flaps and Internal Limiting Membrane Peels.

Retina (Philadelphia, Pa.)·2024

Search research articles

Related Experiment Video

Updated: Mar 31, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Enzymatic Vitrectomy and Pharmacologic Vitreodynamics.

Ankoor R Shah, Michael T Trese

Developments in Ophthalmology

|October 27, 2015

Summary

Pharmacologic agents can liquefy vitreous and induce posterior vitreous detachment (PVD) with a single injection. This approach offers potential for managing vitreoretinopathies and improving surgical outcomes.

Area of Science:

Ophthalmology
Vitreoretinal Surgery
Pharmacology

Background:

Vitreoretinal surgery has advanced significantly due to improved understanding of disease and new techniques.
Pharmacologic agents are emerging for intraocular use to aid vitreous removal and treat vitreoretinal interface pathologies.

Purpose of the Study:

To explore the potential of pharmacologic agents in vitreoretinal surgery.
To evaluate the use of enzymes for vitreous manipulation and posterior vitreous detachment (PVD) induction.

Main Methods:

Review of scientific literature on vitreous liquefaction and PVD induction.
Discussion of pharmacologic agents like plasmin and ocriplasmin for vitreous manipulation.

Main Results:

More Related Videos

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Published on: May 24, 2015

A Step by Step Protocol for Subretinal Surgery in Rabbits

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

Related Experiment Videos

Last Updated: Mar 31, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Whole Vitreous Humor Dissection for Vitreodynamic Analysis

Published on: May 24, 2015

A Step by Step Protocol for Subretinal Surgery in Rabbits

A Step by Step Protocol for Subretinal Surgery in Rabbits

Published on: September 13, 2016

Plasmin can liquefy vitreous and induce PVD.
Intravitreal injection of pharmacologic agents can induce vitreous liquefaction and PVD.
Enzymatic vitrectomy may reduce surgical time and intraoperative complications.

Conclusions:

Pharmacologic vitreodynamics, including enzymatic vitrectomy and induced PVD, holds significant potential for managing vitreoretinopathies.
These advancements may reduce surgical time, facilitate removal of vitreous, and decrease intraoperative complications.
Further understanding of vitreous molecular dynamics will drive the importance of pharmacologic vitreodynamics.